Clinical Trials on Idiopathic Anosmia in Australia

Total 286 results

CSL Limited

Completed

Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients

Idiopathic Thrombocytopenic Purpura (ITP)

Australia
Bayside Health
National Health and Medical Research Council, Australia; Monash University

Recruiting

Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery (ITACS)

Anaemia

Australia
Protalex, Inc.

Terminated

Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP

Idiopathic Thrombocytopenic Purpura (ITP)

Australia, New Zealand
Alpine Immune Sciences, Inc.

Recruiting

An Open-label Study of Povetacicept in Subjects With Autoimmune Cytopenias (RUBY-4)

Immune Thrombocytopenia | Idiopathic Thrombocytopenic Purpura | Cold Agglutinin Disease | Warm Autoimmune Hemolytic Anemia

United States, Canada, Australia, Turkey, United Kingdom
Vifor Pharma
Pierrel Research Europe GmbH

Completed

Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women (ASAP)

Anaemia

Australia, Germany, Sweden, Switzerland, Turkey
Endeavor Biomedicines, Inc.

Completed

A Drug-Drug Interaction Study of ENV-101 (Taladegib) on Nintedanib Pharmacokinetics in Healthy Subjects

Idiopathic Pulmonary Fibrosis

Australia
siRNAgen Therapeutics Inc.

Active, not recruiting

The First-in-human Study of SRN-001 in Healthy Participants

Idiopathic Pulmonary Fibrosis

Australia
Medical University of Graz

Active, not recruiting

Severe Immune Cytopenia Registry Www.Sic-reg.Org (sic-reg)

Primary Immunodeficiency | Immune Thrombocytopenia | Autoimmune Hemolytic Anemia | Evans Syndrome

Austria
Vienna Institute for Research in Ocular Surgery

Completed

Diagnostic Reliability of OCT Biomarkers for iERM

Idiopathic Epiretinal Membranes

Austria
The Ludwig Boltzmann Institute of Retinology and...

Completed

Trypan Blue Versus Brillant Blue for Epiretinal Membranes

Idiopathic Epiretinal Membranes

Austria
Novartis

Completed

Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload

Myelodysplastic Syndromes | Hemoglobinopathies | Diamond-Blackfan Anemia | Transfusional Iron Overload | Other Inherited or Acquired Anaemia | MPD Syndrome | Other Rare Anaemias

Australia
Pulmongene Ltd.

Completed

A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of PMG1015

Idiopathic Pulmonary Fibrosis

Australia
The Ludwig Boltzmann Institute of Retinology and...

Completed

Brillant Blue Versus Indocyanine Green for Macular Hole Surgery

Idiopathic Macular Holes

Austria
The Prince Charles Hospital
Mater Medical Research Institute

Completed

A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis (MSC in IPF)

Idiopathic Pulmonary Fibrosis

Australia
GlaxoSmithKline

Completed

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Purpura, Thrombocytopaenic, Idiopathic

United States, Australia, New Zealand
Hoffmann-La Roche

Completed

A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.

Idiopathic Thrombocytopenic Purpura

Australia
Vifor Pharma
ICON Clinical Research; American Regent, Inc.

Completed

Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (FIND-CKD)

Chronic Kidney Disease | Iron Deficiency Anaemia

United Kingdom, United States, Australia, Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Italy, Netherlands, Norway, Poland, Portugal, Romania, Spain, Sweden, Turkey
Syndax Pharmaceuticals
DevPro Biopharma

Recruiting

Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

Australia
Bayside Health
Monash University

Completed

Association of Postoperative Anaemia With Patient-centred Outcomes

Anemia After Surgery

Australia
Kezar Life Sciences, Inc.

Withdrawn

A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP (MARINA)

Immune Thrombocytopenia | Autoimmune Hemolytic Anemia

Poland, United States, Australia, Italy, Russian Federation
Pfizer
Pfizer

Completed

A Study to Evaluate GBT021601 in Single and Multiple Doses in Healthy Participants

Sickle Cell Disease

Australia, United States
Nemysis Ltd
RDC Clinical Pty Ltd

Recruiting

Safety and Effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal Women

Iron-deficiency

Australia
Bayside Health

Unknown

The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or Angioedema

Angioedema | Urticaria

Australia
Ionis Pharmaceuticals, Inc.

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 702843 Administered Subcutaneously to Healthy Volunteers

Thalassemia

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

The Evaluating Multidisciplinary Bone Marrow Failure Care in Bone Marrow Failure and Related Disorders. (EMBRACE)

Aplastic Anemia | Bone Marrow Failure Syndrome

Australia
Zai Lab Pty. Ltd.

Unknown

Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects

Chronic Obstructive Pulmonary Disease | Asthma | Idiopathic Pulmonary Fibrosis

Australia
Octapharma

Completed

Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults

Immune Thrombocytopenic Purpura

Austria
GlaxoSmithKline

Completed

A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects

Healthy Subjects | Anaemia

Australia
BioAge Labs, Inc.

Withdrawn

Study to Evaluate Efficacy and Safety of BGE-117 in Moderately to Severely Anemic Older Individuals After Major Hip Surgery

Acute Posthemorrhagic Anemia

Australia
Biosplice Therapeutics, Inc.

Withdrawn

A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

Australia, New Zealand
Andreas Guenther

Active, not recruiting

Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank (eurIPFreg)

Idiopathic Pulmonary Fibrosis | Idiopathic Interstitial Pneumonia | Interstitial Lung Diseases | Diffuse Parenchymal Lung Diseases

United Kingdom, Germany, Austria, Italy, France
Keros Therapeutics, Inc.

Recruiting

A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia).

Iron Deficiency Anemia

Australia, Israel, Romania
Amgen

Completed

Study of Haemodialysis Patients Switching From Aranesp to Biosimilar (SHADE)

Anaemia

Australia, Italy, Poland, Germany, Greece, Bulgaria, Spain
GlaxoSmithKline

Completed

Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects

Anaemia

Australia
South Australian Health and Medical Research Institute
Flinders University

Completed

Do Iron Supplements Impact the Gut Microbiome of Women of Reproductive Age?

Iron-deficiency | Anemia | Microbial Colonization

Australia
Kepler University Hospital

Terminated

Oral Iron Substitution for Orthopedic Surgery

Iron Deficiency Anemia

Austria
Natalie Allen
South West Sydney Local Health District

Terminated

Walking Capacity in Parkinson's Disease (PD-Walk)

Idiopathic Parkinson's Disease

Australia
Kira Pharmacenticals (US), LLC.

Completed

To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Doses of KP104

Paroxysmal Nocturnal Hemoglobinuria

Australia
South Eastern Sydney Local Health District
GlaxoSmithKline

Unknown

The International ITP Registry

Thrombocytopenia

Singapore, Korea, Republic of, Thailand, Turkey, Australia, Colombia, Kuwait, Malaysia, Taiwan, Uruguay
Dr. Christopher Lambers
Clinical Trials Coordination Centre, Medical University of Vienna

Withdrawn

Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis | Lung Transplant; Complications

Austria
Sir Charles Gairdner Hospital

Completed

Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients

Anemia | Kidney Failure, Chronic

Australia
Medical University of Graz

Completed

SpHb Perioperatively

Anemia | Anemia, Iron Deficiency

Austria
Mein Hanusch-Krankenhaus

Unknown

Preoperative Supplementation of Sucrosomal Iron as Hematopoietic Support. (Preop Iron)

Anemia, Iron-Deficiency

Austria
Vanderbilt University Medical Center
Patient-Centered Outcomes Research Institute; Johns Hopkins University; University... and other collaborators

Completed

Treatment Alternatives in iSGS (NoAAC PR-02 Study) (NoAAC PR-02)

Idiopathic Subglottic Stenosis (iSGS)

United States, Australia, Iceland, United Kingdom
AbbVie

Recruiting

Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis. (SELECT-sJIA)

Juvenile Idiopathic Arthritis

United States, Japan, Turkey, Australia, China, Spain, Italy, Germany
Algernon Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough

Idiopathic Pulmonary Fibrosis

Australia, New Zealand
Kepler University Hospital

Completed

Prediction of Transfusion-Associated Complications (PRETRACO)

Transfusion-dependent Anemia

Austria
Kepler University Hospital

Completed

Machine Learning-Based Prediction of Major Perioperative Allogeneic Blood Requirements in Cardiac Surgery (PREMATRICS)

Transfusion-dependent Anemia

Austria
Medical University of Graz
Johannes Kepler University of Linz; Fresenius Kabi Austria GmbH, Graz

Completed

Sucrosomal Iron Supplementation in Blood Donors

Iron-deficiency

Austria
Novartis Pharmaceuticals

Completed

An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study)

Thalassemia, Non-transfusional-dependent Thalassemia (NTDT), Myeloplastic Dysplasia (MDS), Other Anemia

Australia

Clinical Trials on Idiopathic Anosmia in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations